• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Molecular Mechanisms in Alzheimer's Disease.

作者信息

Stavljenic-Rukavina Ana

机构信息

Zagreb University School of Medicine, Clinical Institute of Laboratory Diagnosis Zagreb Clinical Hospital Center, School of Medicine, University of Zagreb, Kišpaticeva 12, 10 000 Zagreb Croatia.

出版信息

EJIFCC. 2004 Aug 31;15(3):100-103. eCollection 2004 Aug.

PMID:29988919
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6034191/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c0e/6034191/83804e91896b/ejifcc-15-100-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c0e/6034191/0d7ea0f03bef/ejifcc-15-100-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c0e/6034191/eec40f8fc828/ejifcc-15-100-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c0e/6034191/83804e91896b/ejifcc-15-100-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c0e/6034191/0d7ea0f03bef/ejifcc-15-100-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c0e/6034191/eec40f8fc828/ejifcc-15-100-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c0e/6034191/83804e91896b/ejifcc-15-100-g003.jpg

相似文献

1
Molecular Mechanisms in Alzheimer's Disease.阿尔茨海默病的分子机制
EJIFCC. 2004 Aug 31;15(3):100-103. eCollection 2004 Aug.
2
[Molecular basics of Alzheimer's disease].[阿尔茨海默病的分子基础]
Mol Biol (Mosk). 2007 Mar-Apr;41(2):331-45.
3
Molecular genetics of Alzheimer's disease and aging.阿尔茨海默病与衰老的分子遗传学
Methods Find Exp Clin Pharmacol. 2005 Jul;27 Suppl A:1-573.
4
Proteoglycans and the acute-phase response in Alzheimer's disease brain.蛋白聚糖与阿尔茨海默病大脑中的急性期反应
Mol Neurobiol. 1994 Aug-Dec;9(1-3):25-32. doi: 10.1007/BF02816102.
5
[Neuroimaging in Alzheimer's disease: a synthesis and a contribution to the understanding of physiopathological mechanisms].[阿尔茨海默病的神经影像学：对病理生理机制理解的综合与贡献]
Biol Aujourdhui. 2010;204(2):145-58. doi: 10.1051/jbio/2010010. Epub 2010 Jun 21.
6
Inhibitory functioning in Alzheimer's disease.阿尔茨海默病中的抑制功能。
Brain. 2004 May;127(Pt 5):949-64. doi: 10.1093/brain/awh045. Epub 2003 Nov 25.
7
[Mechanisms of neurodegeneration in Alzheimer's disease].[阿尔茨海默病中的神经退行性变机制]
Med Pregl. 2012 Jul-Aug;65(7-8):301-7. doi: 10.2298/mpns1208301j.
8
Identification of potential PKC inhibitors through pharmacophore designing, 3D-QSAR and molecular dynamics simulations targeting Alzheimer's disease.通过基于药效团的设计、3D-QSAR 和针对阿尔茨海默病的分子动力学模拟来鉴定潜在的蛋白激酶 C 抑制剂。
J Biomol Struct Dyn. 2018 Nov;36(15):4029-4044. doi: 10.1080/07391102.2017.1406824. Epub 2017 Dec 13.
9
Neuronal amyloid-β accumulation within cholinergic basal forebrain in ageing and Alzheimer's disease.衰老及阿尔茨海默病中胆碱能基底前脑内的神经元β淀粉样蛋白积聚。
Brain. 2015 Jun;138(Pt 6):1722-37. doi: 10.1093/brain/awv024. Epub 2015 Mar 1.
10
Molecular and biochemical features in Alzheimer's disease.阿尔茨海默病的分子和生化特征。
Curr Pharm Des. 2006;12(33):4389-408. doi: 10.2174/138161206778792967.

引用本文的文献

1
Cerebrovascular Dysfunction in Alzheimer's Disease and Transgenic Rodent Models.阿尔茨海默病及转基因啮齿动物模型中的脑血管功能障碍
J Exp Neurol. 2024;5(2):42-64. doi: 10.33696/neurol.5.087.
2
Amyloid beta accumulation in TgF344-AD rats is associated with reduced cerebral capillary endothelial Kir2.1 expression and neurovascular uncoupling.TgF344-AD 大鼠脑内淀粉样β沉积与脑毛细血管内皮 Kir2.1 表达减少和神经血管解偶联有关。
Geroscience. 2023 Oct;45(5):2909-2926. doi: 10.1007/s11357-023-00841-2. Epub 2023 Jun 16.
3
Dysregulated miRNAs as Biomarkers and Therapeutical Targets in Neurodegenerative Diseases.

本文引用的文献

1
Apolipoprotein E polymorphism and serum concentration in Alzheimer's disease in nine European centres: the ApoEurope study. ApoEurope group.
Clin Chem Lab Med. 2000 Aug;38(8):721-30. doi: 10.1515/CCLM.2000.102.
2
The presenilins and Alzheimer's disease.早老素与阿尔茨海默病。
Hum Mol Genet. 1997;6(10):1639-46. doi: 10.1093/hmg/6.10.1639.
3
Amyloid, the presenilins and Alzheimer's disease.淀粉样蛋白、早老素与阿尔茨海默病
Trends Neurosci. 1997 Apr;20(4):154-9. doi: 10.1016/s0166-2236(96)01030-2.
失调的微小RNA作为神经退行性疾病的生物标志物和治疗靶点
J Pers Med. 2022 May 10;12(5):770. doi: 10.3390/jpm12050770.
4
Exploring the etiology of Alzheimer disease using molecular genetics.利用分子遗传学探索阿尔茨海默病的病因。
JAMA. 1997 Mar 12;277(10):825-31.
5
The presenilin genes: a new gene family involved in Alzheimer disease pathology.早老素基因：一个参与阿尔茨海默病病理学的新基因家族。
Hum Mol Genet. 1996;5 Spec No:1449-55. doi: 10.1093/hmg/5.supplement_1.1449.
6
No founder effect in three novel Alzheimer's disease families with APP 717 Val-->Ile mutation. Clerget-darpoux. French Alzheimer's Disease Study Group.
J Med Genet. 1996 Aug;33(8):661-4. doi: 10.1136/jmg.33.8.661.
7
The frequency of apolipoprotein E4 allele is not increased in patients with probable vascular dementia.载脂蛋白E4等位基因在可能患有血管性痴呆的患者中频率并未增加。
Acta Neurol Scand. 1996 May;93(5):352-4. doi: 10.1111/j.1600-0404.1996.tb00008.x.
8
Japanese siblings with missense mutation (717Val --> Ile) in amyloid precursor protein of early-onset Alzheimer's disease.患有早发性阿尔茨海默病淀粉样前体蛋白错义突变（717Val --> Ile）的日本兄弟姐妹。
Neurology. 1996 Jun;46(6):1721-3. doi: 10.1212/wnl.46.6.1721.
9
Apolipoprotein E4 allele as a predictor of cholinergic deficits and treatment outcome in Alzheimer disease.载脂蛋白E4等位基因作为阿尔茨海默病胆碱能缺陷和治疗结果的预测指标。
Proc Natl Acad Sci U S A. 1995 Dec 19;92(26):12260-4. doi: 10.1073/pnas.92.26.12260.
10
Genetic association between intronic polymorphism in presenilin-1 gene and late-onset Alzheimer's disease. Alzheimer's Disease Collaborative Group.早老素-1基因内含子多态性与晚发型阿尔茨海默病的遗传关联。阿尔茨海默病协作组。
Lancet. 1996 Feb 24;347(9000):509-12. doi: 10.1016/s0140-6736(96)91140-x.